Laila Agrawal, MD IF
@lailaagrawalmd.bsky.social
Medical oncologist @ Norton Cancer Institute, Louisville KY
Breast cancer specialist | Sexual health after cancer | Community onc | Opinions my own
Breast cancer specialist | Sexual health after cancer | Community onc | Opinions my own
Part 2⃣Studies of HRT in breast cancer coming in 🔥🔥🔥@ASCO #ASCO25!!
Addition of progesterone to letrozole x 2 weeks pre-op in HR+ breast cancer has similar ⬇️Ki67 (marker of proliferation) to letrozole alone.
Fewer hot flashes 🥵, more dizziness 😵💫
Addition of progesterone to letrozole x 2 weeks pre-op in HR+ breast cancer has similar ⬇️Ki67 (marker of proliferation) to letrozole alone.
Fewer hot flashes 🥵, more dizziness 😵💫
June 1, 2025 at 3:05 PM
Part 2⃣Studies of HRT in breast cancer coming in 🔥🔥🔥@ASCO #ASCO25!!
Addition of progesterone to letrozole x 2 weeks pre-op in HR+ breast cancer has similar ⬇️Ki67 (marker of proliferation) to letrozole alone.
Fewer hot flashes 🥵, more dizziness 😵💫
Addition of progesterone to letrozole x 2 weeks pre-op in HR+ breast cancer has similar ⬇️Ki67 (marker of proliferation) to letrozole alone.
Fewer hot flashes 🥵, more dizziness 😵💫
Studies of HRT in breast cancer coming in 🔥🔥🔥 #ASCO25!!@ascocancer.bsky.social
🐎Conjugated estrogens/bazodoxifene (a SERM like tamoxifen) pre-op x 28 days in DCIS ⬇️Ki67 (marker of proliferation) with no difference in quality of life.
Sets the stage for more studies of CE/BZA in #bcsm
🐎Conjugated estrogens/bazodoxifene (a SERM like tamoxifen) pre-op x 28 days in DCIS ⬇️Ki67 (marker of proliferation) with no difference in quality of life.
Sets the stage for more studies of CE/BZA in #bcsm
June 1, 2025 at 3:03 PM
Studies of HRT in breast cancer coming in 🔥🔥🔥 #ASCO25!!@ascocancer.bsky.social
🐎Conjugated estrogens/bazodoxifene (a SERM like tamoxifen) pre-op x 28 days in DCIS ⬇️Ki67 (marker of proliferation) with no difference in quality of life.
Sets the stage for more studies of CE/BZA in #bcsm
🐎Conjugated estrogens/bazodoxifene (a SERM like tamoxifen) pre-op x 28 days in DCIS ⬇️Ki67 (marker of proliferation) with no difference in quality of life.
Sets the stage for more studies of CE/BZA in #bcsm
VERITAC-2: Vepdegestrant showed improved progression free survival in metastatic breast cancer with ESR1 mutation 🧬
As a community oncologist, thrilled that we could offer this trial to our patients close to their homes 🏠 and now see it published today in @nejm.org and presented at #ASCO25
#bcsm
As a community oncologist, thrilled that we could offer this trial to our patients close to their homes 🏠 and now see it published today in @nejm.org and presented at #ASCO25
#bcsm
In advanced breast cancer, progression-free survival was significantly longer with vepdegestrant than with fulvestrant among patients with ESR1 mutations but not in the full patient population. Full VERITAC-2 phase 3 trial results: nej.md/3ZoCL7g
#ASCO25 @ascocancer.bsky.social
#ASCO25 @ascocancer.bsky.social
May 31, 2025 at 2:51 PM
Impressive overall survival benefit with the addition of inavolisib to palbo-fulvestrant in PIK3CA mutated 🧬 HR+ metastatic breast cancer in the INAVO120 study published in @nejm.org today and presented at #ASCO25
⬆️ hyperglycemia, stomatitis, GI and 👁️ side effects
#bcsm @oncoalert.bsky.social
⬆️ hyperglycemia, stomatitis, GI and 👁️ side effects
#bcsm @oncoalert.bsky.social
INAVO120 trial: In patients with PIK3CA-mutated advanced breast cancer, inavolisib added to palbociclib–fulvestrant led to a significant overall survival benefit, with a higher incidence of certain toxic effects than placebo. nej.md/3Zje7Vt
#ASCO25 @ascocancer.bsky.social
#ASCO25 @ascocancer.bsky.social
May 31, 2025 at 2:22 PM
Impressive overall survival benefit with the addition of inavolisib to palbo-fulvestrant in PIK3CA mutated 🧬 HR+ metastatic breast cancer in the INAVO120 study published in @nejm.org today and presented at #ASCO25
⬆️ hyperglycemia, stomatitis, GI and 👁️ side effects
#bcsm @oncoalert.bsky.social
⬆️ hyperglycemia, stomatitis, GI and 👁️ side effects
#bcsm @oncoalert.bsky.social
Reposted by Laila Agrawal, MD IF
Great presentation by Dr Bauman at #ASCO25 highlights that there are many ways patients make decisions, with different priorities for their care.
May 31, 2025 at 1:15 PM
Great presentation by Dr Bauman at #ASCO25 highlights that there are many ways patients make decisions, with different priorities for their care.
Reposted by Laila Agrawal, MD IF
Kicked off Day 2 of #ASCO25 with coffee in the Advocate Lounge
Now looking forward to this session on facilitating informed discussions around evidence-based supportive care
Now looking forward to this session on facilitating informed discussions around evidence-based supportive care
May 31, 2025 at 1:17 PM
Kicked off Day 2 of #ASCO25 with coffee in the Advocate Lounge
Now looking forward to this session on facilitating informed discussions around evidence-based supportive care
Now looking forward to this session on facilitating informed discussions around evidence-based supportive care
Fantastic chapter on digital media highlighting benefits and pitfalls of tools like social media and AI
Thrilled this is published!! All about what you need to know about digital media, AI and gamification for #MedEd! Come to our session Monday 6/2 11:30am CST to learn more! @jhundal.bsky.social
#ASCO25
#ASCO25
Leveling Up: Harnessing Cutting-Edge Technology to Enhance Oncology Education and Learning
The integration and utilization of digital media, gamified learning strategies, and
artificial intelligence (AI) are fundamentally transforming the landscape of oncology
education and learning. These ...
ascopubs.org
May 30, 2025 at 1:42 AM
Fantastic chapter on digital media highlighting benefits and pitfalls of tools like social media and AI
Don’t miss our session on sexual health at #ASCO25 with @lizoriordan.bsky.social and Lawrence Jenkins.
May 24, 2025 at 12:41 PM
Don’t miss our session on sexual health at #ASCO25 with @lizoriordan.bsky.social and Lawrence Jenkins.
So much great research coming out at #ASCO25 that will have a major impact for patients with #breastcancer
And as a community med onc, thrilled to see new data come out for several agents we have in clinical trials & can offer to our patients close to home! 🏡
And as a community med onc, thrilled to see new data come out for several agents we have in clinical trials & can offer to our patients close to home! 🏡
The #ASCO25 #OncoAlertTOP10 Abstracts in #BreastCancer
These are some of our picks of TOP abstracts we look forward to be presented at the upcoming ASCO Meeting in Chicago🇺🇸
@elisaagostinetto.bsky.social
@erikahamilton9.bsky.social
@drsgraff.bsky.social
@elisabettabonzano.bsky.social
These are some of our picks of TOP abstracts we look forward to be presented at the upcoming ASCO Meeting in Chicago🇺🇸
@elisaagostinetto.bsky.social
@erikahamilton9.bsky.social
@drsgraff.bsky.social
@elisabettabonzano.bsky.social
May 24, 2025 at 12:09 PM
So much great research coming out at #ASCO25 that will have a major impact for patients with #breastcancer
And as a community med onc, thrilled to see new data come out for several agents we have in clinical trials & can offer to our patients close to home! 🏡
And as a community med onc, thrilled to see new data come out for several agents we have in clinical trials & can offer to our patients close to home! 🏡
Reposted by Laila Agrawal, MD IF
The #ASCO25 #OncoAlertTOP10 Abstracts in #BreastCancer
These are some of our picks of TOP abstracts we look forward to be presented at the upcoming ASCO Meeting in Chicago🇺🇸
@elisaagostinetto.bsky.social
@erikahamilton9.bsky.social
@drsgraff.bsky.social
@elisabettabonzano.bsky.social
These are some of our picks of TOP abstracts we look forward to be presented at the upcoming ASCO Meeting in Chicago🇺🇸
@elisaagostinetto.bsky.social
@erikahamilton9.bsky.social
@drsgraff.bsky.social
@elisabettabonzano.bsky.social
May 23, 2025 at 10:05 AM
The #ASCO25 #OncoAlertTOP10 Abstracts in #BreastCancer
These are some of our picks of TOP abstracts we look forward to be presented at the upcoming ASCO Meeting in Chicago🇺🇸
@elisaagostinetto.bsky.social
@erikahamilton9.bsky.social
@drsgraff.bsky.social
@elisabettabonzano.bsky.social
These are some of our picks of TOP abstracts we look forward to be presented at the upcoming ASCO Meeting in Chicago🇺🇸
@elisaagostinetto.bsky.social
@erikahamilton9.bsky.social
@drsgraff.bsky.social
@elisabettabonzano.bsky.social
Thank you for highlighting our 📕chapter on sexual health! @ascocancer.bsky.social @lizoriordan.bsky.social
Sexual health concerns after cancer are common, but too often go unaddressed. Authors discuss for #ASCOEdBook: brnw.ch/21wSNMs
May 23, 2025 at 2:51 AM
Thank you for highlighting our 📕chapter on sexual health! @ascocancer.bsky.social @lizoriordan.bsky.social
Reposted by Laila Agrawal, MD IF
This 👇🏾 is for every #oncology clinician who treats #AYA.
Seriously actionable practical education and care offered in this piece. BRAVO @lailaagrawalmd.bsky.social et. al
#AYACSM #sexualhealth #lateandlongterm
Seriously actionable practical education and care offered in this piece. BRAVO @lailaagrawalmd.bsky.social et. al
#AYACSM #sexualhealth #lateandlongterm
Sexual health concerns after cancer are common, but too often go unaddressed. Authors discuss for #ASCOEdBook: brnw.ch/21wSNMs
May 21, 2025 at 5:58 PM
This 👇🏾 is for every #oncology clinician who treats #AYA.
Seriously actionable practical education and care offered in this piece. BRAVO @lailaagrawalmd.bsky.social et. al
#AYACSM #sexualhealth #lateandlongterm
Seriously actionable practical education and care offered in this piece. BRAVO @lailaagrawalmd.bsky.social et. al
#AYACSM #sexualhealth #lateandlongterm
Reposted by Laila Agrawal, MD IF
Sexual health concerns after cancer are common, but too often go unaddressed. Authors discuss for #ASCOEdBook: brnw.ch/21wSNMs
May 21, 2025 at 4:00 PM
Reposted by Laila Agrawal, MD IF
Sexual health concerns after cancer are common, but too often go unaddressed. Authors discuss for #ASCOEdBook: brnw.ch/21wSNMs
May 21, 2025 at 10:51 AM
Excited to share that our ASCO Educational Book chapter on sexual health after cancer is now published! Grateful for the opportunity to highlight this vital, often overlooked part of survivorship care.
#CancerSurvivorship #SexualHealth
#CancerSurvivorship #SexualHealth
Enhancing Sexual Health for Cancer Survivors
Changes to sexual function after cancer treatment are extremely prevalent, affecting
up to 90% of female patients with cancer and 40%-85% of male patients with cancer.
Sexual health concerns include l...
ascopubs.org
April 7, 2025 at 5:29 PM
Excited to share that our ASCO Educational Book chapter on sexual health after cancer is now published! Grateful for the opportunity to highlight this vital, often overlooked part of survivorship care.
#CancerSurvivorship #SexualHealth
#CancerSurvivorship #SexualHealth
Reposted by Laila Agrawal, MD IF
Hot tips from #ASCOAdvocacySummit #ASCOAdvocacy:
A Media Interview (or high profile meeting) is the WRONG TIME for an original thought. Stay on message! Come prepared.
Preach! 🙌🏻 🗣️
@ascocancer.bsky.social @lymphomadoc.bsky.social @ishwaria.bsky.social
A Media Interview (or high profile meeting) is the WRONG TIME for an original thought. Stay on message! Come prepared.
Preach! 🙌🏻 🗣️
@ascocancer.bsky.social @lymphomadoc.bsky.social @ishwaria.bsky.social
April 7, 2025 at 2:35 PM
Hot tips from #ASCOAdvocacySummit #ASCOAdvocacy:
A Media Interview (or high profile meeting) is the WRONG TIME for an original thought. Stay on message! Come prepared.
Preach! 🙌🏻 🗣️
@ascocancer.bsky.social @lymphomadoc.bsky.social @ishwaria.bsky.social
A Media Interview (or high profile meeting) is the WRONG TIME for an original thought. Stay on message! Come prepared.
Preach! 🙌🏻 🗣️
@ascocancer.bsky.social @lymphomadoc.bsky.social @ishwaria.bsky.social